A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis Summary The purpose of this study is to evaluate clinical effectiveness and safety of BMS-986322 in participants with moderate-to-severe psoriasis.
View Eligibility Criteria Eligibility Criteria Inclusion Criteria: Diagnosis of plaque psoriasis (PsO) for ≥ 6 months Body mass index 18 to 40 kg/m^2 and total body weight > 50 kg (110 lbs) Deemed by Investigator to be eligible for phototherapy or systemic therapy Psoriatic plaques must cover ≥ 10% of body surface area at baseline Psoriasis Area and Severity Index (PASI) score ≥ 12 and static Physician Global Assessment (sPGA) ≥ 3 at baseline Exclusion Criteria: Diagnosis of non-plaque psoriasis (guttate, inverse, pustular, erythrodermic) Diagnosis of uveitis, inflammatory bowel disease, or other immune-mediated conditions that are commonly associated with PsO for which a participant requires current systemic immunosuppressant medical treatment Any significant acute or chronic medical illness Other protocol-defined inclusion/exclusion criteria apply
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 53 Locations for this study
Total Skin and Beauty Dermatology Center, PC Birmingham Alabama, 35205, United States
More Info
Alliance Dermatology Phoenix Arizona, 85032, United States
Raoof MD Encino California, 91436, United States
More Info
First OC Dermatology - Fountain Valley Fountain Valley California, 92708, United States
More Info
Center For Dermatology Clinical Research, Inc. Fremont California, 94538, United States
More Info
Dermatology Research Associates - Howard Sofen, MD Los Angeles California, 90045, United States
More Info
Wallace Skin & Body Institute Los Angeles California, 90056, United States
More Info
Southern California Dermatology, Inc Santa Ana California, 92701, United States
More Info
Coral Gables Dermatology & Aesthetics Coral Gables Florida, 33134, United States
Renstar Medical Research Ocala Florida, 34470, United States
More Info
Dermatology Specialists Research - Indiana Clarksville Indiana, 47129, United States
More Info
Northeast Dermatology Associates, P.C. - Beverly Beverly Massachusetts, 01915, United States
More Info
Allcutis Research, LLC - 155 Borthwick Portsmouth New Hampshire, 03801, United States
More Info
Duke Dermatology Clinic - Clinic 3K Durham North Carolina, 27710, United States
More Info
Case Western Reserve University Cleveland Ohio, 44106, United States
More Info
University Hospitals Cleveland Medical Center Cleveland Ohio, 44106, United States
More Info
Palmetto Clinical Trial Services, LLC - Greenville Greenville South Carolina, 29615, United States
More Info
Center for Clinical Studies (CCS) - Webster/Clear Lake Location Webster Texas, 77598, United States
More Info
Premier Clinical Research Spokane Washington, 99202, United States
Local Institution - 0024 Brisbane Queensland, 4102, Australia
More Info
Local Institution - 0019 Carlton Victoria, 3053, Australia
More Info
Local Institution - 0045 Pascoe Vale South Victoria, 3044, Australia
More Info
Local Institution - 0034 Barrie Ontario, L4M 7, Canada
More Info
Local Institution - 0020 Hamilton Ontario, L8L 3, Canada
More Info
Local Institution - 0041 London Ontario, N6A 2, Canada
Local Institution - 0015 Richmond Hill Ontario, L4C 9, Canada
More Info
Local Institution - 0030 Toronto Ontario, M2N 3, Canada
More Info
Local Institution - 0022 Novy Jicin CZ, 741 0, Czechia
More Info
Local Institution - 0028 Ostrava MO, 70200, Czechia
More Info
Local Institution - 0018 Prague , 100 0, Czechia
More Info
Local Institution - 0021 Praha 1 , 11000, Czechia
More Info
Local Institution - 0052 Reims Marne, 51100, France
More Info
Local Institution - 0038 Martigues , 13500, France
More Info
Local Institution - 0036 Rouen , 76031, France
More Info
Local Institution - 0053 Saint-Priest-En-Jarez , 42270, France
More Info
Local Institution - 0048 Toulon , 83000, France
More Info
Local Institution - 0049 Sapporo-Shi Hokkaido, 064-0, Japan
More Info
Local Institution - 0051 Fukuoka-shi , 814-0, Japan
More Info
Local Institution - 0023 Itabashi-Ku , 173-8, Japan
More Info
Local Institution - 0042 Itabashi-Ku , 173-8, Japan
More Info
Local Institution - 0026 Nagoya-Shi , 467-8, Japan
More Info
Local Institution - 0027 Tsu City , 514-8, Japan
More Info
Local Institution - 0035 Wroclaw DS, 50-56, Poland
More Info
Local Institution - 0039 Lodz LD, 90-26, Poland
More Info
Local Institution - 0033 Lodz LD, 90-41, Poland
More Info
Local Institution - 0043 Warszawa MZ, 01-14, Poland
More Info
Local Institution - 0040 Warszawa MZ, 01-81, Poland
Local Institution - 0017 Warszawa MZ, 02-96, Poland
More Info
Local Institution - 0025 Lodz , 90-43, Poland
More Info
Local Institution - 0031 Wroclaw , 51-68, Poland
More Info
Local Institution - 0037 Barcelona , 08040, Spain
More Info
Local Institution - 0050 Hinckley LEC, LE10 , United Kingdom
More Info
Local Institution - 0046 Leytonstone LND, E11 1, United Kingdom
More Info
Local Institution - 0054 London LND, N20 9, United Kingdom
More Info
Local Institution - 0047 Liverpool Merseyside, L1 9E, United Kingdom
More Info How clear is this clinincal trial information?